Adjuvant Chemotherapy After Neoadjuvant FOLFIRINOX Treatment Beneficial for Some Pancreatic Cancer Patients—But Not All
A study evaluated the effect of adjuvant chemotherapy on overall survival in pancreatic cancer patients following resection and neoadjuvant combination treatment with folinic acid,...
New Onset Diabetes and Weight Loss Associated with Pancreatic Cancer Risk
A new study observed a correlation between newly diagnosed diabetes and recent weight loss and an increased likelihood of pancreatic cancer.
Despite pancreatic cancer’s status...
Study Shows Pancreatic Cancer Patients Benefit from Immunotherapy
Results from “COMBAT Trial” show pancreatic cancer patients can greatly benefit from immunotherapy. The results were published in Nature Medicine.
This prospective, open label trial...
Hem/Onc Round-up: Cancer Treatment and Fertility, Osteopathic Medicine for Chemo Relief, and more
Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read about cancer treatment and fertility in...
Surgical Delays Due to COVID-19 are Associated with Shorter Survival Times in Patients with...
Surgical delays due to SARS-CoV-2 (COVID-19) are linked with shorter survival times in colorectal cancer, according to a new study published in the Journal...
Intraperitoneal Paclitaxel Addition May Be Beneficial for Patients with Pancreatic Cancer and Peritoneal Metastasis
A phase I/II study examined treatment strategies for patients with pancreatic cancer and peritoneal metastasis. After assessing a combination of intravenous gemcitabine, intravenous nab‐paclitaxel,...
Interview: Defactinib Plus Pembrolizumab and Gemcitabine Effective in Pancreatic Cancer Patients
A study presented as part of the American Association for Cancer Research virtual meeting found promising results for defactinib combined with pembrolizumab and gemcitabine...
